Skip to main content
. 2014 Jun 22;9(3):273–283. doi: 10.1007/s11899-014-0219-0

Fig. 1.

Fig. 1

Survival of PMBCL patients treated with different chemotherapy regimens – retrospective analysis of the Polish Lymphoma Research Group. Treatment outcomes of patients treated with different chemotherapy regimens: standard R-CHOP-21, dose-dense (R-CHOP-14), and dose-intense (GMALL B-ALL/NHL 2002 protocol and HDT/autoSCT) regimens